Charles Rudin

129PUBLICATIONS

908CO-AUTHORS

Predictive and prognostic markersMolecular targetsGenomics and transcriptomicsTumour immunologyHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (129)

Sort by Publication Date:

|Jun 24, 2026

The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.

|Jun 22, 2026

SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma.

|Jun 18, 2026

L1CAM signaling through planar cell polarity drives SOX2 expression and lung adenocarcinoma metastasis.

|Jun 17, 2026

Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.

|Jun 12, 2026

Hierarchical classification of immune cell transcriptomes at population-scale.

|May 14, 2026

Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer.

Pageof 22

Frequent Collaborators

19 joint publications

John T Poirier

14 joint publications

Natasha Rekhtman

13 joint publications

Bob T Li

13 joint publications

Michael Offin

11 joint publications

Helena Yu

11 joint publications

Álvaro Quintanal-Villalonga

11 joint publications

Alexander Drilon

11 joint publications

Matthew D Hellmann

10 joint publications

Adam J Schoenfeld

8 joint publications

Elisa de Stanchina

Frequent Collaborators

19 joint publications

John T Poirier

14 joint publications

Natasha Rekhtman

13 joint publications

Bob T Li

13 joint publications

Michael Offin